US Patent 11773085 Methods and compounds for treating disorders

Is a

Patent

Patent attributes

Patent Applicant

Foghorn Therapeutics

Current Assignee

Foghorn Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11773085

Patent Inventor Names

Qianhe Zhou

Michael Bocker

Jason T. Lowe

Francois Brucelle

Sabine K. Ruppel

David Simon Millan

Luis Soares

Ho Man Chan

...

Date of Patent

October 3, 2023

Patent Application Number

16942021

Date Filed

July 29, 2020

Patent Citations

‌

US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors

‌

US Patent 9410943 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

‌

US Patent 10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

‌

US Patent 10646575 Heterocyclic degronimers for target protein degradation

‌

US Patent 10660968 Spirocyclic degronimers for target protein degradation

‌

US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation

‌

US Patent 11185592 Spirocyclic degronimers for target protein degradation

‌

US Patent 10905768 Heterocyclic degronimers for target protein degradation

...

Patent Primary Examiner

CPC Code

Patent abstract

The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11773085 Methods and compounds for treating disorders

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11773085 Methods and compounds for treating disorders